Cargando…
Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs
Due to extensive bioprospecting efforts of the past and technology factors, there have been questions about drug discovery prospect from untapped species. We analyzed recent trends of approved drugs derived from previously untapped species, which show no sign of untapped drug-productive species bein...
Autores principales: | Zhu, Feng, Ma, Xiao Hua, Qin, Chu, Tao, Lin, Liu, Xin, Shi, Zhe, Zhang, Cun Long, Tan, Chun Yan, Chen, Yu Zong, Jiang, Yu Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394748/ https://www.ncbi.nlm.nih.gov/pubmed/22808057 http://dx.doi.org/10.1371/journal.pone.0039782 |
Ejemplares similares
-
Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance
por: Peraman, Ramalingam, et al.
Publicado: (2021) -
What Does It Take to Synergistically Combine Sub-Potent Natural Products into Drug-Level Potent Combinations?
por: Qin, Chu, et al.
Publicado: (2012) -
Adenylosuccinic Acid: An Orphan Drug with Untapped Potential
por: Rybalka, Emma, et al.
Publicado: (2023) -
The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
por: Matias, Mariana, et al.
Publicado: (2021) -
Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020)